Media coverage
2
Media coverage
Title Fox Chase Cancer Center: Choice of First-Line Platinum Regimen Does Not Significantly Impact Efficacy of Second-Line Immunotherapy in Advanced Bladder Cancer Media name/outlet Targeted News Service Country/Territory United States Date 06/4/21 Persons Daniel Geynisman Title ASCO 2021: Choice of first-line platinum regimen does not significantly impact efficacy of second-li... Media name/outlet E Cancer Country/Territory United Kingdom Date 06/4/21 URL https://ecancer.org/en/news/20413-asco-2021-choice-of-first-line-platinum-regimen-does-not-significantly-impact-efficacy-of-second-line-immunotherapy-in-advanced-bladder-cancer Persons Daniel Geynisman